158 related articles for article (PubMed ID: 11263438)
21. Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation.
Damle RN; Fais F; Ghiotto F; Valetto A; Albesiano E; Wasil T; Batliwalla FM; Allen SL; Schulman P; Vinciguerra VP; Rai KR; Gregersen PK; Ferrarini M; Chiorazzi N
Curr Top Microbiol Immunol; 2000; 252():285-92. PubMed ID: 11125486
[No Abstract] [Full Text] [Related]
22. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
[TBL] [Abstract][Full Text] [Related]
23. Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course.
Chang CC; Cleveland RP
Blood; 2002 Aug; 100(3):1106. PubMed ID: 12150158
[No Abstract] [Full Text] [Related]
24. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
[TBL] [Abstract][Full Text] [Related]
25. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38.
Bourne T; Zukowska-Cooper M; Salaman MR; Seifert MH; Isenberg DA
Clin Exp Immunol; 1998 Mar; 111(3):611-6. PubMed ID: 9528907
[TBL] [Abstract][Full Text] [Related]
27. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
[TBL] [Abstract][Full Text] [Related]
28. Increased CD38 expression is associated with favorable prognosis in adult acute leukemia.
Keyhani A; Huh YO; Jendiroba D; Pagliaro L; Cortez J; Pierce S; Pearlman M; Estey E; Kantarjian H; Freireich EJ
Leuk Res; 2000 Feb; 24(2):153-9. PubMed ID: 10654451
[TBL] [Abstract][Full Text] [Related]
29. Thrombin induces the association of cyclic ADP-ribose-synthesizing CD38 with the platelet cytoskeleton.
Torti M; Festetics ET; Bertoni A; Sinigaglia F; Balduini C
FEBS Lett; 1998 May; 428(3):200-4. PubMed ID: 9654134
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of ADP-ribosyl cyclase activity of the cell surface antigen CD38 by zinc ions resulting from inhibition of its NAD+ glycohydrolase activity.
Kukimoto I; Hoshino S; Kontani K; Inageda K; Nishina H; Takahashi K; Katada T
Eur J Biochem; 1996 Jul; 239(1):177-82. PubMed ID: 8706705
[TBL] [Abstract][Full Text] [Related]
31. CD38 in hematopoietic malignancies.
Konopleva M; Rissling I; Andreeff M
Chem Immunol; 2000; 75():189-206. PubMed ID: 10851785
[No Abstract] [Full Text] [Related]
32. 3rd CD38 International Workshop. Paris, France, October 23-25, 1997. Abstracts.
J Biol Regul Homeost Agents; 1997; 11 Suppl 1():1-52. PubMed ID: 9476526
[No Abstract] [Full Text] [Related]
33. Retinoid-mediated signaling in CD38 antigen expression.
Mehta K
Chem Immunol; 2000; 75():20-38. PubMed ID: 10851777
[No Abstract] [Full Text] [Related]
34. CD34high+ CD38(low/-) cells generated in a xenogenic coculture system are capable of both long-term hematopoiesis and multiple differentiation.
Tsuji T; Itoh K; Nishimura-Morita Y; Watanabe Y; Hirano D; Mori KJ; Yatsunami K
Leukemia; 1999 Sep; 13(9):1409-19. PubMed ID: 10482993
[TBL] [Abstract][Full Text] [Related]
35. CD38 in hematopoiesis.
Campana D; Suzuki T; Todisco E; Kitanaka A
Chem Immunol; 2000; 75():169-88. PubMed ID: 10851784
[No Abstract] [Full Text] [Related]
36. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).
Mainou-Fowler T; Dignum HM; Proctor SJ; Summerfield GP
Leuk Lymphoma; 2004 Mar; 45(3):455-62. PubMed ID: 15160906
[TBL] [Abstract][Full Text] [Related]
37. CD38 in health and disease.
Bofill M; Borthwick NJ
Chem Immunol; 2000; 75():218-34. PubMed ID: 10851787
[No Abstract] [Full Text] [Related]
38. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.
Dorrell C; Gan OI; Pereira DS; Hawley RG; Dick JE
Blood; 2000 Jan; 95(1):102-10. PubMed ID: 10607692
[TBL] [Abstract][Full Text] [Related]
39. Topology of CD38.
De Flora A; Franco L; Guida L; Bruzzone S; Usai C; Zocchi E
Chem Immunol; 2000; 75():79-98. PubMed ID: 10851780
[No Abstract] [Full Text] [Related]
40. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
